PDS Biotechnology (PDSB) Short Interest Ratio & Short Volume $1.30 -0.02 (-1.52%) Closing price 07/10/2025 04:00 PM EasternExtended Trading$1.30 -0.01 (-0.38%) As of 07/10/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDS Biotechnology Short Interest DataPDS Biotechnology (PDSB) has a short interest of 1.99 million shares, representing 4.79% of the float (the number of shares available for trading by the public). This marks a -31.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.1, indicating that it would take 4.1 days of the average trading volume of 473,059 shares to cover all short positions.Current Short Interest1,990,000 sharesPrevious Short Interest2,900,000 sharesChange Vs. Previous Month-31.38%Dollar Volume Sold Short$3.48 millionShort Interest Ratio4.1 Days to CoverLast Record DateJune 15, 2025Outstanding Shares45,710,000 sharesShort Percent of Float4.79%Today's Trading Volume881,717 sharesAverage Trading Volume473,059 sharesToday's Volume Vs. Average186% Short Selling PDS Biotechnology? Sign up to receive the latest short interest report for PDS Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPDSB Short Interest Over TimePDSB Days to Cover Over TimePDSB Percentage of Float Shorted Over Time PDS Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20251,990,000 shares $3.48 million -31.4%4.8%4.1 $1.75 5/31/20252,900,000 shares $3.94 million +0.7%8.6%6.2 $1.36 5/15/20252,880,000 shares $3.89 million -3.0%8.5%3.9 $1.35 4/30/20252,970,000 shares $4.16 million -1.0%N/A4.9 $1.40 4/15/20253,000,000 shares $3.33 million -4.5%8.9%4.9 $1.11 3/31/20253,140,000 shares $3.74 million -18.7%9.3%5.1 $1.19 3/15/20253,860,000 shares $4.75 million -17.3%11.4%6.3 $1.23 2/28/20254,670,000 shares $6.21 million +20.7%13.8%7.4 $1.33 2/15/20253,870,000 shares $6.04 million -3.5%11.4%9.8 $1.56 1/31/20254,010,000 shares $6.58 million -2.4%N/A10.6 $1.64 Get the Latest News and Ratings for PDSB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PDS Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 1/15/20254,110,000 shares $5.96 million +1.2%N/A10.3 $1.45 12/31/20244,060,000 shares $6.62 million -4.0%N/A10.1 $1.63 12/15/20244,230,000 shares $7.78 million +9.0%N/A9.5 $1.84 11/30/20243,880,000 shares $8.50 million +0.3%N/A9.2 $2.19 11/15/20243,870,000 shares $7.78 million -13.4%N/A9.9 $2.01 10/31/20244,470,000 shares $14.26 million -6.9%N/A14.3 $3.19 10/15/20244,800,000 shares $15.50 million +0.2%N/A16.1 $3.23 9/30/20244,790,000 shares $18.30 million +3.9%N/A14.2 $3.82 9/15/20244,610,000 shares $13.83 million -3.2%N/A11.2 $3.00 8/31/20244,760,000 shares $15.23 million -5.4%N/A10.7 $3.20 8/15/20245,030,000 shares $16.25 million -0.8%N/A10.4 $3.23 7/31/20245,070,000 shares $18.05 million -11.1%N/A8.8 $3.56 7/15/20245,700,000 shares $24.08 million -18.6%N/A9.1 $4.23 6/30/20247,000,000 shares $20.51 million +3.7%N/A10.4 $2.93 6/15/20246,750,000 shares $18.80 million +0.6%N/A8.7 $2.79 5/31/20246,710,000 shares $20.00 million -2.0%N/A8.2 $2.98 5/15/20246,850,000 shares $23.98 million -0.2%N/A7.3 $3.50 4/30/20246,860,000 shares $22.98 million -3.9%N/A7.6 $3.35 4/15/20247,140,000 shares $20.13 million +16.1%N/A7.7 $2.82 3/31/20246,150,000 shares $24.35 million +11.6%N/A6.7 $3.96 3/15/20245,510,000 shares $27.00 million +9.5%N/A7 $4.90 2/29/20245,030,000 shares $33.15 million +0.4%N/A7.1 $6.59 2/15/20245,010,000 shares $27.35 million -5.1%N/A8.4 $5.46 1/31/20245,280,000 shares $28.25 million +1.9%N/A8.6 $5.35 1/15/20245,180,000 shares $22.38 million +5.5%N/A9.2 $4.32 12/31/20234,910,000 shares $24.40 million +4.7%N/A9.8 $4.97 12/15/20234,690,000 shares $23.92 million -3.5%N/A9 $5.10 11/30/20234,860,000 shares $25.56 million -7.4%N/A9.9 $5.26 11/15/20235,250,000 shares $33.18 million -4.9%N/A11.3 $6.32 10/31/20235,520,000 shares $23.02 million -6.3%N/A12 $4.17[No Brainer Gold Play]: “Show me a better investment.” (Ad)A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Click here to get Garrett’s Top Four picks now. 10/15/20235,890,000 shares $26.56 million +11.8%N/A12.3 $4.51 9/30/20235,270,000 shares $26.61 million +15.3%N/A9.9 $5.05 9/15/20234,570,000 shares $24.40 million +6.5%N/A7.9 $5.34 8/31/20234,290,000 shares $25.18 million +7.8%N/A6.4 $5.87 8/15/20233,980,000 shares $23.40 million +0.5%N/A3.9 $5.88 7/31/20233,960,000 shares $22.63 million -5.5%N/A4.3 $5.72 7/15/20234,190,000 shares $21.49 million +8.0%N/A4.7 $5.13 6/30/20233,880,000 shares $19.52 million +32.0%N/A4.5 $5.03 6/15/20232,940,000 shares $18.29 million +9.7%N/A3.5 $6.22 5/31/20232,680,000 shares $25.67 million +27.0%N/A3.9 $9.58 5/15/20232,110,000 shares $14.62 million No ChangeN/A6.1 $6.93 4/30/20232,110,000 shares $12.83 million +3.4%N/A5.9 $6.08 4/15/20232,040,000 shares $14.06 million +2.5%N/A4.9 $6.89 3/31/20231,990,000 shares $12.24 million +7.6%N/A4.3 $6.15 3/15/20231,850,000 shares $12.27 million +1.7%N/A3.1 $6.63 2/28/20231,820,000 shares $13.92 million +15.2%N/A3 $7.65 2/15/20231,580,000 shares $13.84 million -3.7%N/A2.5 $8.76 1/31/20231,640,000 shares $13.66 million +9.3%N/A1.6 $8.33 1/15/20231,500,000 shares $15.57 million +5.6%N/A1.5 $10.38 12/30/20221,420,000 shares $18.74 million +34.0%N/A1.4 $13.20 12/15/20221,060,000 shares $10.01 million -2.8%N/A1.3 $9.44 11/30/20221,090,000 shares $9.84 million -26.4%N/A1.4 $9.03 11/15/20221,480,000 shares $12.85 million +5.7%N/A2.1 $8.68 10/31/20221,400,000 shares $7.34 million +6.9%N/A5.7 $5.24 10/15/20221,310,000 shares $5.23 million +0.8%N/A5.4 $3.99 9/30/20221,300,000 shares $3.86 million -6.5%N/A5.9 $2.97 9/15/20221,390,000 shares $5.45 million -6.1%N/A6 $3.92 8/31/20221,480,000 shares $6.20 million -1.3%N/A5.3 $4.19 8/15/20221,500,000 shares $8.69 million -10.2%N/A2.4 $5.79 7/31/20221,670,000 shares $7.15 million -5.1%N/A2.5 $4.28 7/15/20221,760,000 shares $7.00 million -6.9%N/A2.7 $3.98 6/30/20221,890,000 shares $6.90 million +0.5%N/A3 $3.65 6/15/20221,880,000 shares $6.07 million +20.5%N/A3 $3.23 5/31/20221,560,000 shares $6.12 million +4.0%N/A2.6 $3.92 5/15/20221,500,000 shares $6.84 million +2.0%N/A5.6 $4.56 4/30/20221,470,000 shares $8.13 million +1.4%N/A5.8 $5.53 4/15/20221,450,000 shares $8.12 million +0.7%N/A4.6 $5.60 3/31/20221,440,000 shares $8.91 million +0.7%N/A4.2 $6.19 3/15/20221,430,000 shares $7.81 million +14.4%N/A4 $5.46 2/28/20221,250,000 shares $7.48 million +50.7%N/A3.2 $5.98 2/15/2022829,500 shares $5.72 million +32.5%N/A2.1 $6.90 1/31/2022625,900 shares $3.73 million -5.5%N/A1.5 $5.96 1/15/2022662,000 shares $4.51 million +4.8%N/A1.8 $6.82 12/31/2021631,600 shares $5.12 million -10.6%N/A1.7 $8.10 12/15/2021706,800 shares $6.34 million +33.4%N/A1.7 $8.97 11/30/2021529,800 shares $5.22 million -26.5%N/A1.2 $9.85 11/15/2021720,300 shares $7.86 million -6.7%N/A1.6 $10.91 10/29/2021772,000 shares $9.29 million -5.0%N/A1.6 $12.04 10/15/2021812,700 shares $10.02 million +66.2%N/A1.7 $12.33 9/30/2021489,100 shares $7.29 million +10.2%N/A1 $14.90[No Brainer Gold Play]: “Show me a better investment.” (Ad)A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Click here to get Garrett’s Top Four picks now. 9/15/2021443,900 shares $6.79 million -1.6%N/A0.8 $15.30 8/31/2021451,100 shares $7.01 million +11.9%2.0%0.5 $15.55 8/13/2021403,200 shares $4.29 million -19.3%1.8%0.4 $10.65 7/30/2021499,600 shares $5.33 million -18.7%2.3%0.3 $10.67 7/15/2021614,500 shares $6.00 million -26.5%2.9%0.3 $9.77 6/30/2021836,400 shares $10.50 million -31.4%4.2%0.5 $12.55 6/15/20211,220,000 shares $11.22 million +20.8%5.6%0.7 $9.20 5/28/20211,010,000 shares $12.32 million +18.8%5.7%0.5 $12.20 5/14/2021850,500 shares $3.81 million +27.8%N/A0.4 $4.48 4/30/2021665,600 shares $3.80 million -29.0%N/A0.4 $5.71 4/15/2021937,100 shares $4.92 million +207.3%N/A0.6 $5.25 3/31/2021305,000 shares $1.30 million -62.6%N/A0.2 $4.25 3/15/2021816,300 shares $4.61 million +73.6%N/A0.5 $5.65 2/26/2021470,300 shares $2.09 million +38.8%N/A0.5 $4.45 2/12/2021338,900 shares $1.90 million -26.2%N/A0.4 $5.61 1/29/2021458,900 shares $1.18 million +19.2%N/A0.6 $2.57 1/15/2021385,100 shares $1.06 million -40.7%N/A0.8 $2.76 12/31/2020648,900 shares $1.45 million +39.4%N/A1.4 $2.23 12/15/2020465,400 shares $981.99 thousand +8.1%N/A1 $2.11 11/30/2020430,400 shares $912.45 thousand +10.5%N/A0.9 $2.12 11/15/2020389,600 shares $798.68 thousand +10.9%N/A1 $2.05 10/30/2020351,300 shares $751.78 thousand +66.8%N/A0.6 $2.14 10/15/2020210,600 shares $494.91 thousand -32.1%N/A0.3 $2.35 9/30/2020310,000 shares $722.30 thousand -42.8%N/A0.3 $2.33 9/15/2020542,000 shares $1.36 million -22.9%N/A0.3 $2.51 8/31/2020702,900 shares $1.71 million +0.8%N/A0.4 $2.43 8/14/2020697,200 shares $1.95 million -1.5%N/A0.4 $2.79 7/31/2020708,100 shares $2.59 million +4.9%N/A0.4 $3.66 7/15/2020675,200 shares $1.38 million +279.8%N/A0.4 $2.04 PDSB Short Interest - Frequently Asked Questions What is PDS Biotechnology's current short interest? Short interest is the volume of PDS Biotechnology shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 1,990,000 shares of PDSB short. 4.79% of PDS Biotechnology's shares are currently sold short. Learn More on PDS Biotechnology's current short interest. What is a good short interest ratio for PDS Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PDSB shares currently have a short interest ratio of 4.0. Learn More on PDS Biotechnology's short interest ratio. Which institutional investors are shorting PDS Biotechnology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of PDS Biotechnology: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for PDS Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.79% of PDS Biotechnology's floating shares are currently sold short. Is PDS Biotechnology's short interest increasing or decreasing? PDS Biotechnology saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 1,990,000 shares, a decrease of 31.4% from the previous total of 2,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does PDS Biotechnology's short interest compare to its competitors? 4.79% of PDS Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to PDS Biotechnology: Inozyme Pharma, Inc. (7.79%), Tonix Pharmaceuticals Holding Corp. (15.37%), Candel Therapeutics, Inc. (17.18%), DBV Technologies S.A. (0.08%), Sagimet Biosciences Inc. (16.13%), Prima BioMed Ltd (2.96%), Aurora Cannabis Inc. (8.98%), Neurogene Inc. (19.15%), biote Corp. (2.86%), Acelyrin, Inc. (4.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short PDS Biotechnology stock? Short selling PDSB is an investing strategy that aims to generate trading profit from PDS Biotechnology as its price is falling. PDSB shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PDS Biotechnology? A short squeeze for PDS Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PDSB, which in turn drives the price of the stock up even further. How often is PDS Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PDSB, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Inozyme Pharma Short Squeeze Tonix Pharmaceuticals Short Squeeze Candel Therapeutics Short Squeeze DBV Technologies Short Squeeze Sagimet Biosciences Short Squeeze Prima BioMed Short Squeeze Aurora Cannabis Short Squeeze Neurogene Short Squeeze biote Short Squeeze Acelyrin Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PDSB) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PDS Biotechnology Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share PDS Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PDSB Stock Alerts